QC
ASND icon

Quadrature Capital’s Ascendis Pharma A/S ASND Stock Holding History

Quadrature Capital’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
+40,845
New +$9.54M 0.09% 161
2025
Q4 		– Sell
-6,531
Closed -$1.3M – 1254
2025
Q3 		$1.3M Buy
+6,531
New +$1.22M 0.02% 352

Other funds holding ASND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Quadrature Capital's ASND Position: Q2 2026 in Review

Quadrature Capital opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 40,845 shares worth $10.9M. The stake represents 0.09% of the portfolio and ranks #161 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in ASND as recently as Q3 2025.

Quadrature Capital first reported a position in ASND in Q3 2025 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Quadrature Capital held 40,845 shares of Ascendis Pharma A/S worth $10.9M as of Q2 2026.
  • Ascendis Pharma A/S was a new Quadrature Capital position in Q2 2026.
  • Ascendis Pharma A/S made up 0.09% of Quadrature Capital's portfolio in Q2 2026, its #161 holding.
  • Quadrature Capital first reported a position in Ascendis Pharma A/S in Q3 2025 and has held it in 2 quarters since.
  • 113 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.